标题
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
作者
关键词
-
出版物
PHARMACOGENOMICS JOURNAL
Volume 17, Issue 5, Pages 395-402
出版商
Springer Nature
发表日期
2017-06-13
DOI
10.1038/tpj.2017.21
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-Effectiveness of UGT1A1*28 Genotyping in Preventing Severe Neutropenia Following FOLFIRI Therapy in Colorectal Cancer.
- (2016) Solen Pichereau et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy
- (2015) Catrin O. Plumpton et al. EPILEPSIA
- Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription
- (2015) Ritika Kapoor et al. Pharmacogenetics and Genomics
- Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke
- (2015) Christina Mitropoulou et al. PHARMACOGENOMICS
- Is Individualized Medicine More Cost-Effective? A Systematic Review
- (2014) Maximilian H. M. Hatz et al. PHARMACOECONOMICS
- Through a Glass Darkly: Economics and Personalised Medicine
- (2014) Alan Haycox et al. PHARMACOECONOMICS
- Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project
- (2014) Ariel Beresniak et al. PHARMACOECONOMICS
- Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
- (2014) Huey Yi Chong et al. THROMBOSIS RESEARCH
- The Cost-Effectiveness of a Pharmacogenetic Test: A Trial-Based Evaluation of TPMT Genotyping for Azathioprine
- (2014) Alexander J. Thompson et al. VALUE IN HEALTH
- Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues
- (2014) Kathleen Stergiopoulos et al. JAMA Internal Medicine
- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation
- (2013) J Pink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand
- (2013) Waranya Rattanavipapong et al. EPILEPSIA
- The economic value of personalized medicine tests: what we know and what we need to know
- (2013) Kathryn A Phillips et al. GENETICS IN MEDICINE
- Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation
- (2013) Joyce H.S. You Pharmacogenetics and Genomics
- Cost–effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia
- (2013) Michael J Sorich et al. PHARMACOGENOMICS
- Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand
- (2013) Somsak Tiamkao et al. International Journal of Clinical Pharmacy
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis
- (2012) A. LALA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
- (2012) D. Dong et al. NEUROLOGY
- The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency
- (2012) Wendy S. Rubinstein et al. NUCLEIC ACIDS RESEARCH
- The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes
- (2012) Laura Panattoni et al. PHARMACOECONOMICS
- Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel
- (2012) Emily S. Reese et al. PHARMACOTHERAPY
- Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation
- (2012) Joyce H. S. You et al. PLoS One
- A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia
- (2011) Jennifer R. Donnan et al. PEDIATRIC BLOOD & CANCER
- Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
- (2011) Paolo Olgiati et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ticagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome: A Cost-Effectiveness Analysis
- (2011) Daniel J. Crespin et al. VALUE IN HEALTH
- A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders
- (2011) Alessandro Serretti et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature
- (2010) Stefan Vegter et al. DRUG DEVELOPMENT RESEARCH
- Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain
- (2010) Diana Nieves Calatrava et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis
- (2010) Jared T. Hagaman et al. LUNG
- Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
- (2010) Teresa L. Kauf et al. PHARMACOECONOMICS
- Cost Effectiveness of Pharmacogenomics
- (2010) William B. Wong et al. PHARMACOECONOMICS
- Cost–effectiveness analysis in pharmacogenomics
- (2010) Katherine Payne et al. PHARMACOGENOMICS
- Systematic review of pharmacoeconomic studies of pharmacogenomic tests
- (2010) Mathieu Beaulieu et al. PHARMACOGENOMICS
- Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation
- (2009) Julio A. Leey et al. American Journal Geriatric Pharmacotherapy
- Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer
- (2009) Heather Taffet Gold et al. CANCER
- Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
- (2009) Amanda R. Patrick et al.
- Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy
- (2009) J H S You et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
- (2009) Roy H Perlis et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes
- (2009) Stefan Vegter et al. PHARMACOECONOMICS
- A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
- (2009) Lisa M. Meckley et al. PHARMACOECONOMICS
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
- (2008) Bruce R Schackman et al. AIDS
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NICE Cost-Effectiveness Threshold
- (2008) Christopher McCabe et al. PHARMACOECONOMICS
- Cost–effectiveness ofUGT1A1genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer
- (2008) Marko Obradovic et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started